Ticker Details
Viridian Therapeutics, Inc.
IPO Date:	June 16, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.62B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.51 | 2.74%
Avg Daily Range (30 D):	$0.64 | 2.07%
Avg Daily Range (90 D):	$0.56 | 1.95%

Institutional Daily Volume
Avg Daily Volume:	.59M
Avg Daily Volume (30 D):	1.19M
Avg Daily Volume (90 D):	1.32M

Trade Size
Avg Trade Size (Sh.):	68
Avg Trade Size (Sh.) (30 D):	65
Avg Trade Size (Sh.) (90 D):	67

Institutional Trades
Total Institutional Trades:	2,089
Avg Institutional Trade:	$2.09M
Avg Institutional Trade (30 D):	$3.1M
Avg Institutional Trade (90 D):	$2.75M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.93M
Avg Closing Trade (30 D):	$5.15M
Avg Closing Trade (90 D):	$5.73M
Avg Closing Volume:	145.85K

News

Feb 23, 2026 @ 3:26 PM Viridian Therapeutics Stock Up 75%, but One Fund J... Source: Jonathan Ponciano

Dec 31, 2025 @ 3:01 PM How M&A Unlocked A Biotech Rebound In 2025—... Source: Namrata Sen

Dec 15, 2025 @ 3:25 PM Argenx Halts Phase 3 Thyroid Eye Disease Trial, Pe... Source: Vandana Singh

Nov 17, 2025 @ 11:00 AM 4DMT Appoints Kristian Humer as Chief Financial Of... Source: 4D Molecular Therapeutics

Oct 16, 2025 @ 5:00 PM Thyroid Eye Disease Clinical Trial Pipeline Gains ... Source: Delveinsight

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS
Diluted EPS
Revenue	$70.57M	$.08M	$.07M
Gross Profit
Net Income / Loss	$-34.6M	$-100.74M	$-86.91M
Operating Income / Loss	$-40.01M	$-106.77M	$-93.87M
Cost of Revenue
Net Cash Flow	$52.32M	$1.11M	$16.62M
PE Ratio

Splits
Nov 13, 2020	1:15
Nov 07, 2016	1:15